Today, data reported by market analyst Crypto Patel disclosed upcoming token unlocks this week, an activity that is set to release over 568 million in previouslyToday, data reported by market analyst Crypto Patel disclosed upcoming token unlocks this week, an activity that is set to release over 568 million in previously

Crypto Unlocks This Week: ASTER, ZRO, ARB, VANA, ESPORTS To Release 568 Million Tokens and Their Impact on Crypto Prices

2025/12/14 22:10
Okuma süresi: 3 dk
aster

Today, data reported by market analyst Crypto Patel disclosed upcoming token unlocks this week, an activity that is set to release over 568 million in previously locked tokens to public cryptocurrency markets. These upcoming token unlock events might lead to downward pressure on the affected cryptocurrencies, including ASTER, ZRO, ARB, VANA, ESPORTS, STBL, and MERL.

Bitcoin and the majority of crypto assets are still trading in corrections as investors digest the Fed’s cautious December interest rate cut and its impact on risk assets. However, the move by multiple crypto projects to release their tokens this week is set to further delay the consolidation phase as millions of tokens enter circulation and can depress prices if demand doesn’t keep pace.

Projects With Top Token Unlocks This Week

Aster (ASTER)

Aster (ASTER), a decentralized exchange that provides spot and perpetual trading of crypto and stock derivatives with up to 1001x leverage across numerous blockchains, will unlock 78.41 million ASTER tokens valued at $75.36 million on Wednesday this week. As indicated in the data, Aster will release ASTER tokens to the equivalent of 3.41% of its market cap on 17 December 2025.

LayerZero (ZRO)

Second on the list is LayerZero (ZRO), an interoperability protocol that enables efficient and safe communication and transactions across various blockchain networks. As illustrated by the analyst, LayerZero will release 24.68 million ZRO tokens worth $37.42 million to public crypto markets on Saturday, December 20, 2025, equivalent to 10.3% of the current market capitalization.   

Arbitrum (ARB)

Arbitrum (ARB), a Layer-2 scaling solution that helps improve transaction speed and decrease high gas fees on the Ethereum network, followed the list. Arbitrum will unlock 92.63 million ARB tokens valued at $19.78 million on Tuesday, December 16, 2025, representing 1.66% of its market cap.

Vana (VANA)

Vana (VANA), a Layer-1 blockchain network that enables users to retain control of their personal data while converting it into valuable, tokenized assets, is fourth on the list. According to the data, Vana will release 6.12 million worth $17.41 million, constituting 19.9% of its market capitalization on Tuesday, December 16.

Yooldo Games (ESPORTS)

Moving down, Yooldo Games (ESPORTS), a multi-chain Web3 gaming platform where people play games, use centralized exchanges (CEXs) for token access, and earn rewards for their skills and engagements, is in the fifth spot. As per the data, Yooldo will unlock 41.91 million ESPORTS tokens, with a value of $17.22 million, this Friday, December 19, which represents 25.9% of the current market cap.  

Other Projects with Significant Token Releases

As mentioned in the data, other crypto projects with important token unlocks this week include STBL (STBL) and Merlin Chain (MERL). On Tuesday, December 16, STBL, a decentralized stablecoin protocol, will release 288.39 million STBL tokens, with a value of $16.12 million. On the other hand, Merlin Chain, a Bitcoin-native Layer-2 network, will unlock 36.14 million MERL tokens (equivalent to $16.11 million) on Friday, December 19.

The upcoming huge token releases this week hold significant impacts on the dynamics of the cryptocurrency market. With over 568 million tokens expected to enter circulation, the market braces for increased volatility during the week.

Piyasa Fırsatı
Aster Logosu
Aster Fiyatı(ASTER)
$0.6416
$0.6416$0.6416
+7.12%
USD
Aster (ASTER) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Paylaş
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Paylaş
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26